Delivery Order HHSN272201700020I-75N93023F00002

Award Date 8/31/23
Potential Completion Date 2/7/25
Potential Value $1.2M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Taiwan
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Pharmacology Discovery Services Taiwan, Ltd., a Taiwanese for-profit organization. The contract, valued at $1,797,620.00, is a delivery order issued under the larger NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract vehicle. Under this contract,...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,272,675.00 firm fixed price delivery order to Pharmacology Discovery Services Taiwan, LTD., a Taiwanese for-profit organization. This delivery order was issued under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract vehicle. The work focuses on providing NIAID with therapeutic testing...
This federal contract award to Pharmacology Discovery Services Taiwan, LTD. was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The $754,505.00 firm fixed price delivery order funds the provision of murine (mouse) models of bacterial infections to support NIAID's infectious disease research program. This includes...
Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,197,620 firm fixed price delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. Through this vehicle, the Taiwanese contractor will provide preclinical infectious disease modeling services to NIAID through August 2023 to support the agency's research into mechanisms of disease and therapeutic testing....
This federal contract award to Pharmacology Discovery Services Taiwan, LTD. was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The $1,193,205.00 firm fixed price delivery order is for the provision of murine (mouse) models of urinary tract infections caused by antibiotic-resistant bacteria. This work supports NIAID's Preclinical Models of Infectious Diseases program, an ongoing...
Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,170,062.04 delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. This delivery order funds the prime contractor's work providing preclinical disease modeling services to support NIAID's infectious disease research mission. Specifically, Pharmacology Discovery Services Taiwan will supply murine and...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $332,878 delivery order to Pharmacology Discovery Services Taiwan, LTD under the NIAID Preclinical Models of Infectious Diseases 2017-2024 master IDIQ. This cost-plus-award-fee contract will provide pre-clinical models of infectious diseases to support research efforts at NIAID through September 1, 2021. As part of its mission to conduct and support research on infectious, immunologic, and...
Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,747,930 firm fixed price delivery order against the National Institute of Allergy and Infectious Diseases (NIAID) Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. The delivery order is for pre-clinical models of infectious diseases to support therapeutic testing in murine models of bacterial infection, as described in the original solicitation. Work will be performed in Taiwan...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Pharmacology Discovery Services Taiwan, Ltd., a for-profit Taiwanese company that provides preclinical disease modeling services. The $506,429.00 delivery order is for the development and testing of murine (mouse) models of lung infections caused by antibiotic-resistant Pseudomonas aeruginosa bacteria, to support...
Pharmacology Discovery Services Taiwan, LTD. was awarded a $1,187,770 firm fixed price delivery order against the National Institute of Allergy and Infectious Diseases Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity contract. The delivery order is for therapeutic testing in murine models of bacterial thigh, lung, and peritonitis infections to support the National Institute of Allergy and Infectious Diseases' pre-clinical research mission. Work will...

This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Pharmacology Discovery Services Taiwan, Ltd., a for-profit Taiwanese company. The contract, valued at $1,239,019.00, is a delivery order issued under NIAID's Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. Under this delivery order, Pharmacology Discovery Services Taiwan will provide NIAID with a range of preclinical infectious disease models, including bacterial infection models and models of antibiotic-resistant urinary tract infections, to support NIAID's biomedical research mission. The delivery order has a firm fixed price pricing structure and a period of performance through February 7, 2025. No set-aside designation was indicated for this award.

Generated 9/6/24, 9:33 AM